BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 19082467)

  • 1. The expression of CRM1 is associated with prognosis in human osteosarcoma.
    Yao Y; Dong Y; Lin F; Zhao H; Shen Z; Chen P; Sun YJ; Tang LN; Zheng SE
    Oncol Rep; 2009 Jan; 21(1):229-35. PubMed ID: 19082467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of CRM1 in pancreas cancer.
    Huang WY; Yue L; Qiu WS; Wang LW; Zhou XH; Sun YJ
    Clin Invest Med; 2009 Dec; 32(6):E315. PubMed ID: 20003838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of CRM1 in human gliomas and its significance in p27 expression and clinical prognosis.
    Shen A; Wang Y; Zhao Y; Zou L; Sun L; Cheng C
    Neurosurgery; 2009 Jul; 65(1):153-9; discussion 159-60. PubMed ID: 19574837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COPS3 amplification and clinical outcome in osteosarcoma.
    Yan T; Wunder JS; Gokgoz N; Gill M; Eskandarian S; Parkes RK; Bull SB; Bell RS; Andrulis IL
    Cancer; 2007 May; 109(9):1870-6. PubMed ID: 17366602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of immunohistochemical expression of ezrin in non-metastatic high-grade osteosarcoma.
    Ferrari S; Zanella L; Alberghini M; Palmerini E; Staals E; Bacchini P
    Pediatr Blood Cancer; 2008 Apr; 50(4):752-6. PubMed ID: 17886294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of Smad and its signalling cascade in osteosarcoma.
    Won KY; Kim YW; Park YK
    Pathology; 2010 Apr; 42(3):242-7. PubMed ID: 20350217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of the nuclear export protein chromosomal region maintenance/exportin 1/Xpo1 is a prognostic factor in human ovarian cancer.
    Noske A; Weichert W; Niesporek S; Röske A; Buckendahl AC; Koch I; Sehouli J; Dietel M; Denkert C
    Cancer; 2008 Apr; 112(8):1733-43. PubMed ID: 18306389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of platelet-derived growth factor-AA is associated with tumor progression in osteosarcoma.
    Sulzbacher I; Birner P; Trieb K; Träxler M; Lang S; Chott A
    Mod Pathol; 2003 Jan; 16(1):66-71. PubMed ID: 12527715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C-erbB-2 expression and prognostic significance in osteosarcoma.
    Yalçin B; Gedikoğlu G; Kutluk T; Varan A; Akyüz C; Büyükpamukçu M
    Pediatr Blood Cancer; 2008 Aug; 51(2):222-7. PubMed ID: 18421709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Protein expression of Skp2 in osteosarcoma and its relation with prognosis].
    Liao QD; Zhong D; Chen Q
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Jul; 33(7):606-11. PubMed ID: 18667774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ezrin expression predicts survival in stage IIB osteosarcomas.
    Kim MS; Song WS; Cho WH; Lee SY; Jeon DG
    Clin Orthop Relat Res; 2007 Jun; 459():229-36. PubMed ID: 17353802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of microRNA-223/epithelial cell transforming sequence 2 signaling in patients with osteosarcoma.
    Zhang H; Yin Z; Ning K; Wang L; Guo R; Ji Z
    Hum Pathol; 2014 Jul; 45(7):1430-6. PubMed ID: 24784921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor necrosis rate adjusted by tumor volume change is a better predictor of survival of localized osteosarcoma patients.
    Kim MS; Lee SY; Cho WH; Song WS; Koh JS; Lee JA; Yoo JY; Jeon DG
    Ann Surg Oncol; 2008 Mar; 15(3):906-14. PubMed ID: 18163171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and prognostic relevance of centromere protein A in primary osteosarcoma.
    Gu XM; Fu J; Feng XJ; Huang X; Wang SM; Chen XF; Zhu MH; Zhang SH
    Pathol Res Pract; 2014 Apr; 210(4):228-33. PubMed ID: 24440098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of heat shock proteins in osteosarcomas.
    Moon A; Bacchini P; Bertoni F; Olvi LG; Santini-Araujo E; Kim YW; Park YK
    Pathology; 2010; 42(5):421-5. PubMed ID: 20632817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CDH11 expression is associated with survival in patients with osteosarcoma.
    Nakajima G; Patino-Garcia A; Bruheim S; Xi Y; San Julian M; Lecanda F; Sierrasesumaga L; Müller C; Fodstad O; Ju J
    Cancer Genomics Proteomics; 2008; 5(1):37-42. PubMed ID: 18359978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of papillomavirus binding factor in Ewing's sarcoma family of tumors conferring poor prognosis.
    Yabe H; Tsukahara T; Kawaguchi S; Wada T; Sato N; Morioka H; Yabe H
    Oncol Rep; 2008 Jan; 19(1):129-34. PubMed ID: 18097586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated expression of AKT2 correlates with disease severity and poor prognosis in human osteosarcoma.
    Zhu Y; Zhou J; Ji Y; Yu B
    Mol Med Rep; 2014 Aug; 10(2):737-42. PubMed ID: 24919955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selinexor decreases HIF-1α via inhibition of CRM1 in human osteosarcoma and hepatoma cells associated with an increased radiosensitivity.
    von Fallois M; Kosyna FK; Mandl M; Landesman Y; Dunst J; Depping R
    J Cancer Res Clin Oncol; 2021 Jul; 147(7):2025-2033. PubMed ID: 33856525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. XB130 expression in human osteosarcoma: a clinical and experimental study.
    Wang X; Wang R; Liu Z; Hao F; Huang H; Guo W
    Int J Clin Exp Pathol; 2015; 8(3):2565-73. PubMed ID: 26045762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.